Cargando…

A small molecule inhibitor of Rheb selectively targets mTORC1 signaling

The small G-protein Rheb activates the mechanistic target of rapamycin complex 1 (mTORC1) in response to growth factor signals. mTORC1 is a master regulator of cellular growth and metabolism; aberrant mTORC1 signaling is associated with fibrotic, metabolic, and neurodegenerative diseases, cancers, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahoney, Sarah J., Narayan, Sridhar, Molz, Lisa, Berstler, Lauren A., Kang, Seong A., Vlasuk, George P., Saiah, Eddine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803267/ https://www.ncbi.nlm.nih.gov/pubmed/29416044 http://dx.doi.org/10.1038/s41467-018-03035-z

Ejemplares similares

Discovery of NV-5138, the first selective Brain mTORC1 activator
por: Sengupta, Shomit, et al.
Publicado: (2019)

Huntington’s disease phenotypes are improved via mTORC1 modulation by small molecule therapy
por: St-Cyr, Sophie, et al.
Publicado: (2022)

Coordination of Rheb lysosomal membrane interactions with mTORC1 activation
por: Angarola, Brittany, et al.
Publicado: (2020)

Structural Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
por: Yang, Haijuan, et al.
Publicado: (2017)

Ubiquitination of Rheb governs growth factor-induced mTORC1 activation
por: Deng, Lu, et al.
Publicado: (2018)

Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays
por: Shams, Raef, et al.
Publicado: (2021)

Development of an RHEB-Targeting Peptide To Inhibit mTORC1 Kinase Activity
por: Shams, Raef, et al.
Publicado: (2022)

Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
por: Carroll, Bernadette, et al.
Publicado: (2016)

Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex
por: Yasuda, Shin, et al.
Publicado: (2014)

Correction: Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
por: Carroll, Bernadette, et al.
Publicado: (2020)

Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy depletion-induced suppression of mTORC1
por: Zheng, Min, et al.
Publicado: (2011)

Farnesylation-defective Rheb Increases Axonal Length Independently of mTORC1 Activity in Embryonic Primary Neurons
por: Choi, Seunghyuk, et al.
Publicado: (2019)

Persistent Rheb-induced mTORC1 activation in spinal cord neurons induces hypersensitivity in neuropathic pain
por: Ma, Xiaqing, et al.
Publicado: (2020)

Weak membrane interactions allow Rheb to activate mTORC1 signaling without major lysosome enrichment
por: Angarola, Brittany, et al.
Publicado: (2019)

Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
por: Gao, Yanan, et al.
Publicado: (2016)

TSC2/Rheb signaling mediates ERK‐dependent regulation of mTORC1 activity in C2C12 myoblasts
por: Miyazaki, Mitsunori, et al.
Publicado: (2017)

ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells
por: Sohretoglu, Didem, et al.
Publicado: (2019)

Blocking the Farnesyl Pocket of PDEδ Reduces Rheb-Dependent mTORC1 Activation and Survival of Tsc2-Null Cells
por: Armijo, Marisol Estrella, et al.
Publicado: (2022)

mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)

Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
por: Feldman, Morris E, et al.
Publicado: (2009)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)

Mammalian Target of Rapamycin Complex I (mTORC1) Activity in Ras Homologue Enriched in Brain (Rheb)-Deficient Mouse Embryonic Fibroblasts
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia
por: Chiang, Yun-Jung, et al.
Publicado: (2018)

Molecular basis for the functions of dominantly active Y35N and inactive D60K Rheb mutants in mTORC1 signaling
por: Zhang, Chunxiao, et al.
Publicado: (2020)

mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
por: Ding, Xiaolei, et al.
Publicado: (2016)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
por: Merhi, Ahmad, et al.
Publicado: (2017)

Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
por: Du, Heng, et al.
Publicado: (2023)

Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors
por: Burnett, G. Leslie, et al.
Publicado: (2022)

Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
por: Lee, Dongjun, et al.
Publicado: (2014)

VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation
por: Mohan, Nishant, et al.
Publicado: (2016)

Amino Acid-Mediated Intracellular Ca(2+) Rise Modulates mTORC1 by Regulating the TSC2-Rheb Axis through Ca(2+)/Calmodulin
por: Amemiya, Yuna, et al.
Publicado: (2021)

RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
por: Weinberg, Mark A.
Publicado: (2016)

LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion
por: Ribeiro, Marcelle C., et al.
Publicado: (2018)

mTORC1 and mTORC2 differentially promote natural killer cell development
por: Yang, Chao, et al.
Publicado: (2018)

mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
por: Yang, Jin Young, et al.
Publicado: (2019)

Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2
por: Kosillo, Polina, et al.
Publicado: (2022)

mTORC2 Steals the Spotlight
por: Jansen, Laura A.
Publicado: (2020)

Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
por: Luo, Yan, et al.
Publicado: (2015)

A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models
por: Zhang, Hao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_21au05m16tm1gdoqoodn8lv82i